- Home
- KALA vs MDCX Comparison
KALA vs MDCX Comparison
Compare KALA & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KALA | MDCX |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8M | 23.6M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KALA | MDCX |
|---|---|---|
| Price | $0.73 | $0.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $31.50 | $14.50 |
| AVG Volume (30 Days) | 199.5K | ★ 1.7M |
| Earning Date | 04-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $0.25 |
| 52 Week High | $20.58 | $3.12 |
Technical Indicators
Market Signals| Indicator | KALA | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 27.64 | 44.61 |
| Support Level | $0.50 | $0.28 |
| Resistance Level | $1.81 | $0.38 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 0.68 | 15.27 |
Price Performance
Historical ComparisonAbout KALA KALA BIO Inc.
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.